Marta Wilejto/X
Oct 19, 2024, 00:15
Marta Wilejto: Our responsibility is to make Blinatumomab available for all including LMIC
Marta Wilejto, Staff Physician, Pediatric Hematology/Oncology, London Health Sciences Centre, shared a post on X:
“The future (and present) of ALL therapy is Blinatumomab .. this is very clear.
But innovative therapies are expensive. Our responsibility is to make blin available for all including LMIC.
How to do this remains a challenge.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2025, 09:26
Sep 4, 2025, 08:36
Sep 4, 2025, 08:36
Sep 4, 2025, 08:27
Sep 4, 2025, 08:13